Safety is absolutely paramount in the medical industry, with lives literally at stake if something were to go wrong. Regrettably, this was more than reinforced recently following the tragic news of a death of a newborn at a hospital in Sydney, Australia, after it was mistakenly administered nitrous oxide (N2O) instead of oxygen (O2) in July this year.
A tragic occurrence of similar circumstance was literally the reason behind UK-based Bedfont Scientific’s establishment in 1976, with Chairman Trevor Smith emphasising, “It is crucial to have the correct technical and safety practices in place. To put it bluntly, it is a matter of life and death.”
After a patient at a London hospital was administered N2O instead of O2, Bedfont invented the TM3 Gas differentiator – a simple device which could differentiate the two gases and ensure there were no cross-connections. This range has developed over the years and now Bedfont’s entire Medi-gas Check range safeguards patients and staff in accordance with the strictest legislation.
... to continue reading you must be subscribed
